Literature DB >> 8064604

Daunomycin as an inhibitor of human lens epithelial cell proliferation in culture.

W J Power1, D Neylan, L M Collum.   

Abstract

Posterior capsule opacification is still a major complication of both extracapsular cataract extraction and phacoemulsification. We evaluated the effects of the anti-proliferative agent daunomycin on cultured human and bovine lens epithelial cell viability and proliferation. After ten minutes of exposure, low concentrations of the agent markedly inhibited the proliferation of both cell types. The calculated LD50 for the drug against human cells was 2.20 micrograms/ml and against the bovine cells was 0.38 microgram/ml. The bovine cells appeared to be slightly more susceptible to the drug's effects, although this difference was not marked. Our results indicate that daunomycin is a potent inhibitor of both human and bovine lens epithelial cells in the laboratory.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064604     DOI: 10.1016/s0886-3350(13)80579-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

1.  Quantitative measurement of the PCCC area in the postoperative period.

Authors:  Y van Tenten; V De Groot; F L Wuyts; M J Tassignon
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 2.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

3.  Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial.

Authors:  Tanja M Rabsilber; Il-Joo Limberger; Andreas J Reuland; Mike P Holzer; Gerd U Auffarth
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

4.  Evaluation of a human capsular bag model for secondary cataract determination after intraocular lens implantation.

Authors:  A Liekfeld; N Pahms; N Torun; A U Porstmann; J Jaroszewski; C Hartmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-10       Impact factor: 3.117

5.  Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.

Authors:  Jeyalakshmi Sureshkumar; Aravind Haripriya; Veerappan Muthukkaruppan; Paul L Kaufman; Baohe Tian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-03       Impact factor: 3.117

6.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

7.  EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.

Authors:  C Wertheimer; R Liegl; M Kernt; W Mayer; D Docheva; A Kampik; K H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

8.  Findings of an experimental study in a rabbit model on posterior capsule opacification after implantation of hydrophobic acrylic and hydrophilic acrylic intraocular lenses.

Authors:  Nikolaos Trakos; Elli Ioachim; Elena Tsanou; Miltiadis Aspiotis; Konstantinos Psilas; Chris Kalogeropoulos
Journal:  Clin Ophthalmol       Date:  2008-12

9.  Topical exposure of mitomycin C reduces opacification of the residual anterior lens capsule and lenticular regeneration after vitrectomy and lensectomy in rabbits.

Authors:  Takeshi Miyamoto; Shizuya Saika; Yuka Okada; Iku Ishida-Nishikawa; Takayoshi Sumioka; Norihito Fujita; Yoshitaka Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-10       Impact factor: 3.117

10.  Lens epithelial cell regression on the posterior capsule with different intraocular lens materials.

Authors:  E J Hollick; D J Spalton; P G Ursell; M V Pande
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.